Cytori Therapeutics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
August 31 2018 - 9:00AM
Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that it
will present at the 20th Annual Rodman & Renshaw Global
Investment Conference at 09:10 AM Eastern Time on Thursday,
September 6, 2018. The presentation will take place in the
Fontainebleau Foyer room at the St. Regis New York, in New York,
NY. Dr. Marc Hedrick, CEO and President of Cytori Therapeutics,
will provide an update on current corporate activities and recent
developments. Cytori management will be available for one-on-one
meetings at the conference.
About Cytori Therapeutics
Cytori is developing, manufacturing, and commercializing
nanoparticle-delivered oncology drugs and autologous
adipose-derived regenerative cell (ADRC) therapies within its
Nanomedicine™ and Cell Therapy™ franchises, respectively.
Cytori Nanomedicine™ is focused on the liposomal encapsulation of
anti-neoplastic chemotherapy agents, which may enable the effective
delivery of the agents to target sites while reducing systemic
toxicity. The Cytori Nanomedicine™ product pipeline consists
of ATI-0918 pegylated liposomal doxorubicin hydrochloride for
breast cancer, ovarian cancer, multiple myeloma, and Kaposi’s
sarcoma, a complex/hybrid generic drug, and ATI-1123 patented
albumin-stabilized pegylated liposomal docetaxel for multiple solid
tumors. Cytori Cell Therapy™, prepared within several hours
with the proprietary Celution® System and administered to the
patient the same day, has been shown in preclinical and clinical
studies to act principally by improving blood flow, modulating the
immune system, and facilitating wound repair. As a result, Cytori
Cell Therapy™ may provide benefits across multiple disease states
and can be made available to the physician and patient at the
point-of-care. For more information, visit
www.cytori.com.
Cytori Therapeutics, Inc.
Tiago Girao, +1 (858) 458.0900
ir@cytori.com
Cytori Therapeutics (NASDAQ:CYTX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cytori Therapeutics (NASDAQ:CYTX)
Historical Stock Chart
From Sep 2023 to Sep 2024